2020 annual financial data

Recursion Pharmaceuticals 2020 Financial results

Direct answer

Revenue was 3,413,000 USD.

Operating income was -84,615,000 USD and net income was -87,006,000 USD.
Operating cash flow was -45,399,000 USD.

Get free Recursion Pharmaceuticals email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Revenue
3,413,000 USD
Operating income
-84,615,000 USD
Net income
-87,006,000 USD
Operating cash flow
-45,399,000 USD